Saudi Central Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Saudi Central Bank's VRTX Position: Q2 2026 in Review
Saudi Central Bank increased its Vertex Pharmaceuticals (VRTX) stake by 90% in Q2 2026, buying an estimated $3.74M and bringing the position to 17,805 shares worth $8.84M. The position accounts for 0.12% of the portfolio, ranked #109.
Saudi Central Bank first reported a position in VRTX in Q1 2025 and has held it in 3 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Saudi Central Bank held 17,805 shares of Vertex Pharmaceuticals worth $8.84M as of Q2 2026.
- Saudi Central Bank bought 8,440 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.74M.
- Vertex Pharmaceuticals made up 0.12% of Saudi Central Bank's portfolio in Q2 2026, its #109 holding.
- Saudi Central Bank first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.